<DOC>
<DOCNO>
EP-0006971
</DOCNO>
<TEXT>
<DATE>
19800123
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/41 C07D-285/12 A61P-9/00 A61P-9/12 A61P-9/06 C07D-285/00 A61K-31/433 <main>C07D-285/12</main> 
</IPC-CLASSIFICATIONS>
<TITLE>
amino derivatives of 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazoles, process for their preparation and therapeutical compositions containing them.
</TITLE>
<APPLICANT>
basf agde<sep>basf aktiengesellschaft<sep>basf aktiengesellschaftcarl-bosch-strasse 3867063 ludwigshafende <sep>basf aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
franke albrecht dr <sep>frickel fritz-frieder dr <sep>gries josef dr<sep>hagen helmut dr<sep>lenke dieter dr<sep>thieme peter c dr<sep>franke, albrecht, dr.<sep>frickel, fritz-frieder, dr.<sep>gries, josef, dr.<sep>hagen, helmut, dr.<sep>lenke, dieter, dr.<sep>thieme, peter c., dr.<sep>franke, albrecht, dr.mandelring 11d-6706 wachenheimde<sep>frickel, fritz-frieder, dr.prager strasse 27d-6700 ludwigshafende<sep>gries, josef, dr.roemerweg 43d-6706 wachenheimde<sep>hagen, helmut, dr.max-slevogt-strasse 17 ed-6710 frankenthalde<sep>lenke, dieter, dr.kekuleplatz 1d-6700 ludwigshafende<sep>thieme, peter c., dr.dr.-hans-hoffmann-strasse 5d-6706 wachenheimde<sep>franke, albrecht, dr.<sep>frickel, fritz-frieder, dr.<sep>gries, josef, dr.<sep>hagen, helmut, dr.<sep>lenke, dieter, dr. <sep>thieme, peter c., dr.<sep>franke, albrecht, dr. mandelring 11 d-6706 wachenheim de<sep>frickel, fritz-frieder, dr.prager strasse 27d-6700 ludwigshafende<sep>gries, josef, dr.roemerweg 43d-6706 wachenheimde<sep>hagen, helmut, dr.max-slevogt-strasse 17 ed-6710 frankenthalde<sep>lenke, dieter, dr.kekuleplatz 1d-6700 ludwigshafende<sep>thieme, peter c., dr.dr.-hans-hoffmann-strasse 5d-6706 wachenheimde<sep>
</INVENTOR>
<ABSTRACT>
The invention relates to novel alkylaminopropanol derivatives of the 2-methyl-5-2-hydroxystyryl) -1,3,4-thiadiazole of all mean formula (I), in which R is a hydrogen atom, an alkyl radical having 1 to 8 C atoms, which may optionallyby hydroxy, alkoxy with 1 to 3 C atoms or cycloalkyl with 3 to 8 C atoms in the ring is substituted, an alkenyl or alkynyl radical having 2 to 8 C atoms, a cycloalkyl or cycloalkenyl radical having 3 to 8 C atomsIn the ring, whereby the cycloalkyl rings are possibly one or twice by an alkyl radical with 1 to 3 C atoms substitui, and their physiologically acceptable mat reading salts, methods for their preparation and these compounds containing pharmaceutical forecasts which are for treatmentCoronary heart disease that can be used hypertension and cardiac arrhythmias.
</ABSTRACT>
</TEXT>
</DOC>
